Montelukast for postinfectious cough in adults: A double-blind randomised placebo-controlled trial

The Lancet Respiratory Medicine

Volumn 2, Issue 1, 2014, Pages 35-43

  Wang, Kay ^a   Birring, Surinder S ^b   Taylor, Kathryn ^a   Fry, Norman K ^c   Hay, Alastair D ^d   Moore, Michael ^e   Jin, Jing ^a   Perera, Rafael ^a   Farmer, Andrew ^a   Little, Paul ^e   Harrison, Timothy G ^c   Mant, David ^a   Harnden, Anthony ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST; PLACEBO; ACETIC ACID DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NOSE DISEASE; OUTCOME ASSESSMENT; POSTINFECTIOUS COUGH; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; THROAT TIGHTNESS; TREATMENT DURATION; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; WHEEZING; XEROSTOMIA; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPLICATION; COUGH; MULTICENTER STUDY; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; YOUNG ADULT;

ACETATES; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COUGH; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUINOLINES; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891373320     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70245-5     Document Type: Article

References (46)

1. Ryan NM, Vertigan AE, Ferguson J, Wark P, Gibson PG Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection. Respir Med 2012, 106:138-144.
2. Braman S Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(1 suppl):138S-146S.
3. Seymour ML, Gilby N, Bardin PG, et al. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 2002, 185:540-544.
4. Gentile DA, Fireman P, Skoner DP Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 2003, 91:270-274.
5. Matsuse H, Hirose H, Tsuchida T, et al. Effects of respiratory syncytial virus infection on dendritic cells and cysteinyl leukotrienes in lung tissues of a murine model of asthma. Allergol Int 2007, 56:165-169.
6. Wedde-Beer K, Hu C, Rodriguez MM, Piedimonte G Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1143. L1L50.
7. Kim CK, Koh JY, Han TH, Kim do K, Kim BI, Koh YY Increased levels of BAL cysteinyl leukotrienes in acute [corrected] RSV bronchiolitis. Acta Paediatr 2006, 95:479-485.
8. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RCI, Welliver RC Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999, 103:630-636.
9. Amrani Y, Moore PE, Hoffman R, Shore SA, Panettieri RA Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Respir Crit Care Med 2001, 164:2098-2101.
10. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003, 111:1032-1040.
11. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000, 162:2226-2231.
12. Hansen G, Berry G, DeKruyff RH, Umetsu DT Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999, 103:175-183.
13. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001, 32:1691-1697. the Sentinel Health Unit Surveillance System Pertussis Working Group.
14. Vandebriel RJ, Gremmera ER, Vermeulen JP, et al. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis. Vaccine 2007, 25:2346-2360.
15. Thivierge M, Stankova J, Rola-Pleszczynski M IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 2001, 167:2855-2860.
16. Spector SL, Tan RA Effectiveness of montelukast in the treatment of cough variant asthma. Ann Allergy Asthma Immunol 2004, 93:232-236.
17. Peroni DG, Pescollderungg L, Sandri M, Chinellato I, Boner AL, Piacentini GL Time-effect of montelukast on protection against exercise-induced bronchoconstriction. Respir Med 2011, 105:1790-1797.
18. Zhu L, Kuang J, Deng Z Clinical analysis of montelukast in the treatment of post-infectious cough. China Pharmacy 2011, 22:2067-2069.
19. Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 2008, 178:854-860.
20. Bettiol S, Wang K, Thompson MJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev 2012, 5. CD003257.
21. Fry NK, Litt DJ, Duncan J, et al. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. J Med Microbiol 2013, 62:1281-1289.
22. Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord ID Development of symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003, 58:339-343.
23. Zhao JJ, Rogers JD, Holland SD, et al. Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers. Biopharm Drug Dispos 1997, 18:769-777.
24. Raj AA, Pavord ID, Birring SS Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire?. Handb Exp Pharmacol 2009, 187:311-320.
25. European Medicines Agency. Guideline on missing data in confirmatory clinical trials. July 2, 2010. EMA/CPMP/EWP/1776/99 Rev. 1.
26. Ponsioen BP, Hop WCJ, Vermue NA, Dekhuijzen PNR, Bohnen AM Efficacy of fluticasone on cough: a randomised controlled trial. Eur Respir J 2005, 25:147-152.
27. Woodcock A, McLeod RL, Sadeh J, Smith JA The efficacy of a NOP1 agonist (SCH486757) in subacute cough. Lung 2010, 188(suppl 1):S47-S52.
28. Yousaf N, Lee KK, Jayaraman B, Pavord ID, Birring SS The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute). Cough 2011, 7:4.
29. Lee PC, Jawad MS, Hull JD, West WH, Shaw K, Eccles R The antitussive effect of placebo treatment on cough associated with acute upper respiratory tract infection. Psychosom Med 2005, 67:314-317.
30. Dicpinigaitis PV, Dobkin JB, Reichel J Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma 2002, 39:291-297.
31. Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma. Respiration 2012, 83:308-315.
32. Zimmerman B, Silverman FS, Tarlo SM, Chapman KR, Kubay JM, Urch B Induced sputum: comparison of postinfectious cough with allergic asthma in children. J Allergy Clin Immunol 2000, 105:495-499.
33. Hewitt M, Canning BJ Coughing precipitated by Bordetella pertussis infection. Lung 2010, 188(suppl 1):S73-S79.
34. Noor A, Najmi MH, Bukhtiar S Effect of montelukast on bradykinin-induced contraction of isolated tracheal smooth muscle of guinea pig. Indian J Pharmacol 2011, 43:445-449.
35. Lee KK, Matos S, Evans DH, White P, Pavord ID, Birring SS A longitudinal assessment of acute cough. Am J Respir Crit Care Med 2013, 187:991-997.
36. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000, 38:800-806.
37. Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord ID The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J 2008, 31:1013-1018.
38. Dicpinigaitis PV Cough reflex sensitivity in cigarette smokers. Chest 2003, 123:685-688.
39. Gerrard JW, Cockcroft DW, Mink JT, Cotton DJ, Poonawala R, Dosman JA Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 1980, 122:577-581.
40. Malo JL, Filiatrault S, Martin RR Bronchial responsiveness to inhaled methacholine in young asymptomatic smokers. J Appl Physiol 1982, 52:1464-1470.
41. Ashworth M, Charlton J, Latinovic R, Gulliford M Age-related changes in consultations and antibiotic prescribing for acute respiratory infections, 1995-2000. Data from the UK General Practice Research Database. J Clin Pharm Ther 2006, 31:461-467.
42. Hay AD, Wilson AD The natural history of acute cough in children aged 0-4 years in primary care: a systematic review. Br J Gen Pract 2005, 52:401-409.
43. Kwon N-H, Oh M-J, Min T-H, Lee B-J, Choi D-C Causes and clinical features of subacute cough. Chest 2006, 129:1142-1147.
44. Cherry JD, Tan T, Wirsing von König CH, et al. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis 2012, 54:1756-1764.
45. Jenkins MA, Clark JR, Carlin JB, et al. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol 1996, 25:609-616.
46. Cane RS, Ranganathan SC, McKenzie SA What do parents of wheezy children understand by "wheeze"?. Arch Dis Child 2000, 82:327-332.